RCM Market Intelligence · 2026

Healthcare RCM M&A, private equity and funding

A living guide to the capital reshaping healthcare revenue cycle management—acquisitions, sponsor-backed platforms, venture and growth rounds, IPO activity, ownership changes and the companies becoming strategic infrastructure.

Explore the live deal tracker →Research companies

RCM deal intelligence, connected

M&AAcquisitions, mergers, platform combinations, strategic reviews and asset sales.
Private equityBuyouts, sponsor-backed platforms, growth investments and ownership changes.
Funding & IPOsVenture rounds, growth capital and public-market activity across RCM and adjacent infrastructure.

RCAI's deal database currently spans transactions across enterprise RCM, coding, denials, patient access, payments, prior authorization, revenue integrity, healthcare data and AI-enabled workflow. The useful signal is not just deal count: it is where capital is concentrating and which capabilities are being assembled into broader operating platforms.

Search RCM Deals & Raises →Filter the structured transaction ledger by year, transaction type, company and segment.

Major transactions and capital signals

These RCAI analyses illustrate the recurring themes behind the database: scaled RCM platforms, sponsor consolidation, AI-native workflows, healthcare-data infrastructure and public-market optionality.

Infinx and the RCM public-markets pathFollow the IPO and enterprise RCM scale signal.Carlyle, Knack RCM and the offshore RCM capital cycleTrack sponsor-backed platform formation and IPO optionality.Blackstone and AGS HealthA major private-equity signal for technology-enabled RCM services.Ensemble Health Partners transaction analysisFollow ownership and valuation signals around scaled managed RCM.Waystar strategic-options analysisPublic-market RCM infrastructure meets a new valuation test.

Where capital is concentrating

Recent transactions show capital moving toward platforms that can execute work across multiple parts of the revenue cycle rather than simply surface analytics. Coding, prior authorization, document intelligence, payment infrastructure, denial prevention and specialty workflows are increasingly being acquired or funded as components of broader operating systems.

That makes ownership and transaction history part of vendor diligence. A company's investor base, acquisition strategy and capital structure can affect product integration, pricing, go-to-market priorities and the likelihood of future consolidation.

Connect deals to companies and categories

RCM Market Map →See the competitive landscape across coding, denials, payments, patient access, automation and other RCM categories.Company Intelligence →Move from transaction signals into structured company profiles, ownership context and RCAI research.

Who uses this research

Healthcare finance and RCM leaders can use ownership and transaction intelligence for vendor diligence. Investors and advisors can use it to understand category formation and comparable activity. Vendors can use it to track competitors, buyers, capital sources and emerging platform strategies.